Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants
Condition:   Typhoid Fever Interventions:   Biological: EuTCV (Vi-CRM Typhoid conjugate vaccine);   Biological: Typbar-TCV Sponsor:   EuBiologics Co.,Ltd Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2021 Category: Research Source Type: clinical trials